bi 891065
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 14, 2017 (NCT03166631)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bi 891065
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04138823 | Phase 1 | Nov 11, 2019 | Boehringer Ingelheim |
| NCT03697304 | Phase 2 | Mar 7, 2019 | Boehringer Ingelheim |
| NCT03166631 | Phase 1 | Jul 14, 2017 | Boehringer Ingelheim |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 3 | 3 | 2 | 2017 |
1 organizations
Page 1 / 1